Concepedia

Placebo-controlled trial of rituximab in IgM anti-myelin–associated glycoprotein neuropathy

Jean‐Marc Léger, Karine Viala, Guillaume Nicolas, Alain Créange, Jean‐Michel Vallat, Jean Pouget, Pierre Clavelou, Christophe Vial, Andreas Steck, Lucile Musset,

Neurology · 2013 · 198 citations · 25 references

DOIFull text

Open access

Abstract

This study provides Class I evidence that rituximab is ineffective in improving ISS in patients with IgM anti-MAG demyelinating neuropathy.

References

25

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision

Peter Van den Bergh, Robert D. M. Hadden, P. Bouché et al. · European Journal of Neurology · 2010 · 1.1K citations

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

Richard AC Hughes, Peter D. Donofrio, Vera Bril et al. · The Lancet Neurology · 2008 · 656 citations · Full text

, , +8

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy

Richard AC Hughes, S. Bensa, Hugh J. Willison et al. · Annals of Neurology · 2001 · 617 citations · Full text

, , +14

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision

Journal of the Peripheral Nervous System · 2010 · 554 citations

, , +22

Peripheral Neuropathy

Thomas Chelimsky, Bashar Katirji · Neurology · 1994 · 434 citations